Orsak Gabriela, Miller Anastasia, Allen Carlton M, Singh Karan P, McGaha Paul
Department of Epidemiology and Biostatistics, School of Rural and Community Health, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Tyler, TX, 75708-3154, USA.
Department of Healthcare Policy, Economics and Management, The University of Texas Health Science Center at Tyler, Tyler, TX, USA.
Pharmacoecon Open. 2020 Mar;4(1):71-77. doi: 10.1007/s41669-019-0147-y.
Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it.
We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured.
The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature.
For fiscal years 2016 and 2017, the program provided an average return of $US1.46-2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923.
A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment.
结直肠癌(CRC)是美国第三大常见癌症。其经济影响广泛,因此有必要开展预防性筛查服务以帮助预防该病。
我们试图评估一项在主要为农村地区针对未参保和参保不足人群开展教育及筛查的结直肠癌筛查推广项目在癌症预防成本降低方面的投资回报率。
计算了2016年和2017年德克萨斯州东北部结直肠癌筛查项目的支出。价格(美元)经通胀调整后换算为2017年的价值。使用文献中结直肠癌治疗的估计成本计算节省的成本。
在2016财年和2017财年,该项目每花费1美元税收平均回报为1.46 - 2.06美元。每避免一例病例估计节省成本165,080美元,在检测出的早期癌症病例中估计节省成本245,601美元,潜在节省金额在3,893,676美元至4,837,923美元之间。
在人口密度较低地区开展教育及筛查的结直肠癌推广项目产生了正投资回报率。